×
For best experience we recommend to activate Javascript in your browser.
PPARG antibody
PPARG
Reactivity: Human
WB, ELISA, IHC, IF
Monoclonal
unconjugated
Product Details anti-PPARG Antibody
(hide)
Target
See all PPARG Antibodies
PPARG
(Peroxisome Proliferator-Activated Receptor gamma (PPARG))
Reactivity
All reactivities for PPARG antibodies
Human
Host
Please inquire
Clonality
All clonalities for PPARG antibodies
Monoclonal
Conjugate
All conjugates for PPARG antibodies
This PPARG antibody is un-conjugated
Application
All applications for PPARG antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
Specificity
Ni-NTA purified truncated recombinant PPARG expressed in E. Coli strain BL21 (DE3)
Purification
Crude ascites.
Isotype
IgG1
Top Product
Discover our top product PPARG Primary Antibody
Alternatives
(show)
anti-Peroxisome Proliferator-Activated Receptor gamma (PPARG) (AA 101-200) antibody
PPARG
Reactivity: Human, Mouse, Rat, Cow, Sheep
WB, ELISA, FACS, IF (p), IF (cc), IHC (p), IHC (fro)
Host: Rabbit
Polyclonal
unconjugated
anti-Peroxisome Proliferator-Activated Receptor gamma (PPARG) (pSer273) antibody
PPARG
Reactivity: Human, Mouse, Rat, Sheep, Guinea Pig
WB, ELISA, ICC, IF (p), IF (cc), IHC (p), IHC (fro)
Host: Rabbit
Polyclonal
unconjugated
Application Details
(hide)
Application Notes
Western Blot: 1: 500- 1: 2,000 IHC(P): 1: 500- 1: 2,000 IHC(F): 1: 500- 1: 2,000 IF : 1: 500- 1: 2,000 ELISA: Propose dilution 1: 10,000. Determining optimal working dilutions by titration test.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Storage
-20 °C
References for anti-PPARG antibody (ABIN966887)
(hide)
Yang, Ma, Ma, Fogo : "Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis. " in: Kidney international , Vol. 69 , Issue 10 , pp. 1756-64 , (2006 ) (PubMed ).
Weng, Chen, Pinzone, Ringel, Chen : "Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones. " in: Endocrine-related cancer , Vol. 13 , Issue 2 , pp. 401-13 , (2006 ) (PubMed ).
Ahdjoudj, Kaabeche, Holy, Fromigué, Modrowski, Zérath, Marie : "Transforming growth factor-beta inhibits CCAAT/enhancer-binding protein expression and PPARgamma activity in unloaded bone marrow stromal cells. " in: Experimental cell research , Vol. 303 , Issue 1 , pp. 138-47 , (2004 ) (PubMed ).
Target Details for PPARG
(hide)
Target
PPARG
(Peroxisome Proliferator-Activated Receptor gamma (PPARG))
Alternative Name
PPARG (PPARG Products )
Synonyms
PPAR gamma antibody, PPARg2 antibody, PPARG antibody, Nr1c3 antibody, PPAR-gamma antibody, PPAR-gamma2 antibody, PPARgamma antibody, PPARgamma2 antibody, NR1C3 antibody, CIMT1 antibody, GLM1 antibody, PPARG1 antibody, PPARG2 antibody, xPPAR-gamma antibody, PPAR-GAMMA antibody, PPARGAMMA antibody, peroxisome proliferator-activated receptor gamma antibody, peroxisome proliferator activated receptor gamma antibody, peroxisome proliferator activated receptor gamma L homeolog antibody, PPARG antibody, Pparg antibody, pparg.L antibody
Background
PPAR gamma(PPARG), which encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. Three subtypes of PPARs are known: PPAR-alpha, PPARdelta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described.
Gene ID
5468
Pathways
MAPK Signaling , Nuclear Receptor Transcription Pathway , Steroid Hormone Mediated Signaling Pathway , Negative Regulation of Hormone Secretion , Carbohydrate Homeostasis , Regulation of Lipid Metabolism by PPARalpha , Positive Regulation of Endopeptidase Activity , Brown Fat Cell Differentiation , Positive Regulation of fat Cell Differentiation
Recently viewed
(hide)